Home > Drug Search >
  • company_query: Apitope Technology
  •   > 
Drug Filter
Category:
chemistry (9) biology (33)
Status:
Approved (6) BLA Filing (1) Phase Ⅲ (4) Phase Ⅱ (21) Phase Ⅰ (10)
Clinical Stage:
Pending (4) Active (28) Discontinued (4)
Bio-Type:
Cell therapy (1) Vaccine (12) Allergen extract (1) Recombinant enzyme (1) Recombinant polypeptide (1) Recombinant coagulation factor (3) Recombinant cytokines (4) Recombinant hormone (1) Fusion protein (1)
Indication:
Acute myeloid Leukemia (AML) (5) Anemia (2) Bladder cancer (1) Breast cancer (2) Chronic lymphocytic leukemia (CLL) (1) Chronic myeloid leukemia (CML ) (2) Hookworm infections (1) Cystic fibrosis (CF) (2) Endometrial cancer (2) Urogenital cancer (1) Gastric cancer (1) HBV infection (2) HCV infection (1) Timothy grass pollen-induced allergic rhinitis (1) Melanoma (3) Multiple myeloma (MM) (2) Multiple sclerosis (MS) (2) Myelodysplastic syndrome (MDS) (1) Neuropathic pain (1) Non small cell lung cancer (NSCLC) (1) Non-Hodgkin B-cell lymphomas (1) Osteoporosis (1) Ovarian cancer (2) Postoperative pain (1) HEV infection (1) Prostate cancer (1) Solid tumours (2) Type 2 diabetes (1) Vulvar intraepithelial neoplasia (1) Anal intraepithelial neoplasia (1) Dermatitis (1) Cervical carcinoma (2) B-cell lymphoma (1) Malaria (1) Type 1 diabetes (1) Hemophilia A (3) Neutropenia (3) Condylomata acuminata (1) Spinal cord injury (1) Peritoneum cancer (1) Graft versus host disease (1) Allergic asthma (1) Liver cancer (1) hematological malignancies (1) Central nervous system disorders (1) Human papillomavirus infections (HPV) (1) Hypersensitivity (2)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top